Baidu
map

Nature:研究发现与自闭症有关的三个基因突变

2012-04-10 Benjamin M. Neale 等 Nature

4月2号是第五届世界自闭症日,4月4日Nature杂志在线发表三篇作为特色文章的研究论文表明自闭症与多个基因突变有关。 三个新发现的基因突变与自闭症有关。这些研究成果揭开了自闭症的新的遗传靶标,为自闭症的重要的遗传变化及导致泛自闭障碍(autism spectrum disorders, ASD)的多个生物学途径提供了新的理解。 基因突变是发生在DNA链上的错误,使人具有患某种疾病的风险。在这

4月2号是第五届世界自闭症日,4月4日Nature杂志在线发表三篇作为特色文章的研究论文表明自闭症与多个基因突变有关。

三个新发现的基因突变与自闭症有关。这些研究成果揭开了自闭症的新的遗传靶标,为自闭症的重要的遗传变化及导致泛自闭障碍(autism spectrum disorders, ASD)的多个生物学途径提供了新的理解。

基因突变是发生在DNA链上的错误,使人具有患某种疾病的风险。在这几项研究中鉴定的发生突变的基因—CHD8, SNC2A, and KATNAL2—是通过被称为外显子测序的最新基因组测序技术而发现的。研究人员称,随着对这些基因的进一步定型研究以及对数千个家庭的基因测序,他们将能够为自闭症开发新的治疗方法及预防策略。

“我们现在已经对与自闭症有关的大量基因有了很好的判断,并且已经发现了其中的10%,”西奈山医学院的Joseph Buxbaum博士说。“如果我们要解开与ASD有关的重要基因,我们需要对更多的患者记忆他们的小孩进行研究。这项工作对于促进自闭症的治疗非常关键。”

在研究中,ASD研究人员猜测,自身产生的突变是相当一部分自闭症发生的原因。自身产生的突变指的是那些受影响的小孩中首次出现的突变,是由精子或卵子中的突变发生而来的。

由Buxbaum博士发起的自闭症测序联合会是一个由自闭症遗传学研究者组成的国际团队,他们通过大规模下一代测序对自闭症的遗传学病因进行研究。在这项研究中,他们对超过500个家庭(包括父母与小孩)进行测序研究,检测了基因组上的蛋白质富集区域。

Buxbaum博士说:“当在许多受影响的小孩中发现相同的突变,而在非自闭症小孩中却没有时,我们相信我们发现了通过共同作用对大部分自闭症患者形成影响的突变。我们的研究发现,由这些突变基因所编码的蛋白质之间的发应超过了我们的预期,正是了超过我们预期的重要相关性。”

同期作为特色文章发表在Nature上的另外两篇论文中的其中一篇由耶鲁医学院的Matthew State博士领导完成。他们首次发现数个高度断裂性突变与ASD相关。研究结果表明,在某个基因上的多个变异是形成了ASD的风险因子。另外一篇由华盛顿大学Evan Eichler博士领导完成的研究发现与ASD相关的某些特定突变是亲缘性的。他们的研究结论还支持了此前的研究成果:年龄相对更大的父亲其小孩患ASD的风险更高。(生物谷 bioon.com)

doi:10.1038/nature11011
PMC:
PMID:

Patterns and rates of exonic de novo mutations in autism spectrum disorders

Benjamin M. Neale, Yan Kou, Li Liu, Avi Ma’ayan, Kaitlin E. Samocha, Aniko Sabo, Chiao-Feng Lin, Christine Stevens, Li-San Wang, Vladimir Makarov, Paz Polak, Seungtai Yoon, Jared Maguire, Emily L. Crawford,0 Nicholas G. Campbell,0 Evan T. Geller, Otto Valladares, Chad Schafer, Han Liu, Tuo Zhao, Guiqing Cai, Jayon Lihm, Ruth Dannenfelser, Omar Jabado, Zuleyma Peralta

Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified1, 2. To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3%) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivity among themselves and to previous ASD genes3 as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case–control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.

文献二:De novo mutations revealed by whole-exome sequencing are strongly associated with autism

文献三:Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2188617, encodeId=ad07218861ee4, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Thu Feb 22 08:02:36 CST 2024, time=2024-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879164, encodeId=c39118e916486, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jun 09 06:27:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752958, encodeId=ec4a1e529581d, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sat Jul 21 19:27:00 CST 2012, time=2012-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527514, encodeId=9907152e51478, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Thu Apr 12 12:27:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2024-02-22 1dea4a7em68(暂无匿称)

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2188617, encodeId=ad07218861ee4, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Thu Feb 22 08:02:36 CST 2024, time=2024-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879164, encodeId=c39118e916486, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jun 09 06:27:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752958, encodeId=ec4a1e529581d, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sat Jul 21 19:27:00 CST 2012, time=2012-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527514, encodeId=9907152e51478, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Thu Apr 12 12:27:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2188617, encodeId=ad07218861ee4, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Thu Feb 22 08:02:36 CST 2024, time=2024-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879164, encodeId=c39118e916486, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jun 09 06:27:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752958, encodeId=ec4a1e529581d, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sat Jul 21 19:27:00 CST 2012, time=2012-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527514, encodeId=9907152e51478, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Thu Apr 12 12:27:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2188617, encodeId=ad07218861ee4, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Thu Feb 22 08:02:36 CST 2024, time=2024-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879164, encodeId=c39118e916486, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Jun 09 06:27:00 CST 2012, time=2012-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752958, encodeId=ec4a1e529581d, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Sat Jul 21 19:27:00 CST 2012, time=2012-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527514, encodeId=9907152e51478, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Thu Apr 12 12:27:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 xiongke014

相关资讯

NEJM:中重度阿尔茨海默病患者宜继续服用多奈哌齐

3月8日的《新英格兰医学杂志》(New England Journal of Medicine)上发表的一项随机试验显示,在接受多奈哌齐治疗后病情仍继续加重的中重度阿尔茨海默病(AD)患者中,与追加或转为美金刚以及停用AD药物治疗相比,继续多奈哌齐(爱忆欣)治疗显示出较小但显著的益处,表现为认知和功能性预后改善。该试验为期1年,名为DOMINO(多奈哌齐和美金刚治疗中重度阿尔茨海默病)研究,研究者

PLoS Bio:张建等发现了控制早期中枢神经系统发育的关键母源基因

近日,国际著名杂志PLoS Biology在线刊登了中科院遗传与发育生物学研究所研究人员的最新研究成果“Maternal xNorrin, a Canonical Wnt Signaling Agonist and TGF-β Antagonist, Controls Early Neuroectoderm Specification in Xenopus,”,文章中,研究者发现了控制早期中枢神经

Science:研究发现支持觅食行为的一种大脑活动形式

4月6日,国际著名杂志Science在线刊登了国外研究人员的最新研究成果“Neural Mechanisms of Foraging”,文章中,研究人员发现了支持觅食行为的一种大脑活动形式。 觅食中的动物必须决定是在遇到食物时就选择该食物选项,还是继续寻找以期更好的食物会出现。这与在所有选项同时存在时从中进行挑选不同,而这却是在大多数有关人类决策的研究中要求受试者去做的。 Nils Kolli

JBC:姜黄素能防治帕金森氏病

姜黄素是一种亚洲香料姜黄中的主要化合物,未来或许可以用来治愈帕金森病。据密歇根州立大学的研究人员发现,这种特殊的物质可以预防帕金森病病理有关的蛋白质的凝集。帕金森病是一种中枢神经系统退行性疾病,主要特征为多巴胺的形成和活性不足为特征,另外患者还有路易氏体(Lewy Bodies)的存在。路易氏体是帕金森症的病理标志,它可在黑质脑细胞里的退化细胞中找到。 密歇根州立大学的博士后研究员Basir

Brain:研究发现实验鼠部分脑神经自我修复的机制

近日,日本一个研究小组在最新一期英国杂志《脑》Brain上发表文章说,一侧肢体不能正常活动的实验鼠,其大脑未受损一侧的神经会“补缺”,部分接替受损一侧大脑神经的功能。 日本大阪大学教授山下俊英领导的研究小组说,从左右脑延伸出的神经在脑的延髓处交叉,右脑负责左半身,左脑负责右半身。脑的一侧出现脑血管障碍或脑挫伤等损伤时,相反一侧的手脚就会出现麻痹甚至半身不遂。 研究小组人为损伤了实验鼠左脑,结果

Science:科学家绘制首张大脑皮质图谱

近日,国际著名杂志《科学》Science在线刊登了自加州大学圣地亚哥分校医学院和和VE圣地亚哥医疗系统的研究人员的最新研究成果“Hierarchical Genetic Organization of Human Cortical Surface Area,”,文章中,研究小组在新研究中基于遗传信息成功绘制出了第一张人类大脑表面图谱。 不同于其他的大脑图谱是基于生理学或功能对大脑进行分区,新图谱

Baidu
map
Baidu
map
Baidu
map